Hrt Financial LP Vor Biopharma Inc. Transaction History

Hrt Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.0 - $2.2 $31,855 - $70,081	31,855 New	31,855 $31,000
Q1 2023 May 12, 2023	BUY	$4.68 - $6.96 $109,802 - $163,295	23,462 Added 130.9%	41,386 $222,000
Q4 2022 Feb 10, 2023	BUY	$3.77 - $7.43 $67,573 - $133,175	17,924 New	17,924 $119,000
Q2 2022 Aug 12, 2022	SELL	$3.89 - $6.44 $246,680 - $408,386	-63,414 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$6.04 - $12.23 $254,773 - $515,873	42,181 Added 198.66%	63,414 $383,000
Q4 2021 Feb 14, 2022	BUY	$11.32 - $18.02 $240,357 - $382,618	21,233 New	21,233 $246,000

41.2M

9.3K

100

Ticker VOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,056,300
Market Cap $32.7M
Description
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.